IGM Biosciences IGMS

$ 7.01 -0.57%

Quarterly report 2024-Q3
added 11-08-2024

IGM Biosciences Financial Statements 2011-2024 | IGMS

Annual Financial Statements IGM Biosciences

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	640 M	654 M	558 M	2.69 B	319 M	-	-	-	-	-	-	-	-
Shares	52.3 M	41.5 M	33.5 M	30.7 M	9 M	-	-	-	-	-	-	-	-
Historical Prices	12.2	15.8	16.7	87.4	51.4	-	-	-	-	-	-	-	-
Net Income	-246 M	-221 M	-165 M	-81.4 M	-43.1 M	-22.7 M	-11.1 M	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-263 M	-228 M	-165 M	-83.3 M	-44.5 M	-22.8 M	-11.1 M	-	-	-	-	-	-
Interest Expense	-20 K	-181 K	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-255 M	-222 M	-161 M	-82.3 M	-43.9 M	-22.5 M	-11 M	-	-	-	-	-	-
Operating Expenses	266 M	229 M	165 M	83.3 M	44.5 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	50.1 M	49.7 M	38.3 M	18.2 M	9.24 M	3.83 M	2.51 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement IGM Biosciences

	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	60.7 M	60.4 M	60.1 M	59.6 M	45.1 M	44.5 M	-	44 M	43.9 M	33.8 M	-	33.4 M	33.4 M	33.3 M	31.3 M	30.6 M	30.6 M	30.5 M	30.5 M	4.22 M	560 K	443 K	438 K	438 K	438 K	438 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-61.4 M	-47.9 M	-49.8 M	-62 M	-64.4 M	-59.3 M	-	-58 M	-58.6 M	-51.9 M	-	-44.2 M	-38.7 M	-31.6 M	-24.6 M	-20.3 M	-18.8 M	-17.6 M	-14.8 M	-10.2 M	-10.7 M	-7.47 M	-9.05 M	-6.52 M	-4.22 M	-2.93 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-64.4 M	-51.4 M	-53.9 M	-66.8 M	-68.2 M	-63.4 M	-	-60.5 M	-59.2 M	-52 M	-	-44.2 M	-38.7 M	-31.7 M	-24.7 M	-20.6 M	-19.4 M	-18.6 M	-15.9 M	-10.7 M	-10.5 M	-7.36 M	-9.05 M	-6.54 M	-4.24 M	-2.96 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-20 K	-	-	-131 K	8 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-51.7 M	-	-	-61.7 M	-	-56.3 M	-56.6 M	-50.7 M	-	-41 M	-36.7 M	-31 M	-24.7 M	-20.4 M	-19.2 M	-18.4 M	-15.9 M	-10.5 M	-10.4 M	-7.24 M	-9.05 M	-6.44 M	-4.24 M	-2.96 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	64.9 M	52.6 M	54.4 M	67.3 M	68.7 M	63.9 M	-	60.8 M	59.6 M	52 M	-	44.2 M	38.7 M	31.7 M	24.7 M	20.6 M	19.4 M	18.6 M	15.9 M	10.7 M	10.5 M	7.36 M	9.05 M	6.54 M	4.24 M	2.96 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	18.8 M	10.6 M	10.5 M	12.5 M	13 M	13 M	-	12.7 M	12.4 M	13.1 M	-	10 M	8.65 M	8.13 M	5.14 M	4.73 M	4.39 M	3.99 M	3.17 M	2.39 M	2.23 M	1.44 M	1.23 M	1.37 M	794 K	430 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency